Mylan Takes Actelion Drug IP Fight To Fed. Circ.
Mylan Pharmaceuticals Inc. said Tuesday it's appealing to the Federal Circuit a West Virginia district judge's claim construction order after being blocked from selling a generic version of rival Actelion Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article